Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

A Novel Approach to a Retrospective Longitudinal Analysis of Dose Change or Discontinuation of Imatinib Therapy in Chronic Phase–Chronic Myeloid Leukemia

Serena Merante, MD, Cristiana Pascutto, PhD, Chiara Elena, MD, Barbara Rocca, BSc, Rita Zappatore, PhD, Paola Maria Cavigliano, BSc, Mario Cazzola, MD, Ester Orlandi, MD

Blood (2014) 124 (21): 4543.

https://doi.org/10.1182/blood.V124.21.4543.4543

Published: 2014

Journal Articles

Gene Expression Profiling of CD34+/Lin- Cells of Patients with Chronic Myeloid Leukemia at Diagnosis and after 12 Months of Nilotinib

Alessandra Trojani, Milena Lodola, Barbara Di Camillo, Giuseppe Rossi, MD, Adele Capucci, Alessandra Perego, Enrico Maria Pogliani, MD, Ester Orlandi, MD, Alessandra Iurlo, MD PhD, Simona Malato, Paolo Corradini, MD, Roberto Cairoli, Marco Bregni, Salvatore Artale, Enrica Morra, Ester Pungolino, MD

Blood (2014) 124 (21): 5177.

https://doi.org/10.1182/blood.V124.21.5177.5177

Published: 2014

Journal Articles

Microarray of Bone Marrow CD34+/Lin- Cells from Patients with Chronic Myeloid Leukemia (CML)

Blood (2014) 124 (21): 5178.

https://doi.org/10.1182/blood.V124.21.5178.5178

Published: 2014

Journal Articles

Gimema Registry of Conception/Pregnancy in Adult Patients Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKIs)

Blood (2014) 124 (21): 1806.

https://doi.org/10.1182/blood.V124.21.1806.1806

Published: 2014

Journal Articles

The e13a2 BCR-ABL1 Fusion Transcript Is a Candidate Adverse Prognostic Factor In Chronic Myeloid Leukemia Patients Treated Frontline With Imatinib Mesylate

Blood (2013) 122 (21): 1486.

https://doi.org/10.1182/blood.V122.21.1486.1486

Published: 2013

Journal Articles

A Phase II Multi-Center Trial Of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) In Older Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients

Marco Montillo, MD, Davide Rossi, Marina Motta, MD, Giulia Quaresmini, MD, Marianna Rossi, MD, Marta Coscia, MD, PhD, Antonella Anastasia, MD, Fausto Rossini, MD, Agostino Cortelezzi, MD, Guido Nador, MD, Lydia Scarfò, MD, Roberto Cairoli, MD, Daniela Dal Ceggio, MD, Lorenzo De Paoli, MD, Enrica Morra, MD, Alessandro Rambaldi, MD, Ester Orlandi, MD, Massimo Massaia, MD, Alessandra Tedeschi, MD

Blood (2013) 122 (21): 4177.

https://doi.org/10.1182/blood.V122.21.4177.4177

Published: 2013

Journal Articles

Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL

Anna Vardi, Antonis Dagklis, Lydia Scarfò, Diane Jelinek, Darren Newton, Fiona Bennett, Julia Almeida, Arancha Rodriguez-Caballero, Sallie Allgood, Mark Lanasa, Agostino Cortelezzi, Ester Orlandi, Silvio Veronese, Marco Montillo, Andy Rawstron, Tait Shanafelt, Alberto Orfao, Kostas Stamatopoulos, Paolo Ghia

Blood (2013) 121 (22): 4521–4528.

https://doi.org/10.1182/blood-2012-12-471698

Published: 2013

Includes: Supplemental data

Journal Articles

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms

Marzia Varettoni, Luca Arcaini, Silvia Zibellini, Emanuela Boveri, Sara Rattotti, Roberta Riboni, Alessandro Corso, Ester Orlandi, Maurizio Bonfichi, Manuel Gotti, Cristiana Pascutto, Silvia Mangiacavalli, Giorgio Croci, Valeria Fiaccadori, Lucia Morello, Maria Luisa Guerrera, Marco Paulli, Mario Cazzola

Blood (2013) 121 (13): 2522–2528.

https://doi.org/10.1182/blood-2012-09-457101

Published: 2013

Journal Articles

Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia.

Alessandra Tedeschi, MD, Davide Rossi, MD, Marta Coscia, MD, PhD, Eleonora Vismara, MD, Valeria Belsito Petrizzi, MD, Ester Orlandi, Nicola Cascavilla, Lydia Scarfò, MD, Marina Motta, MD, Candida Vitale, MD, Francesca Ricci, MD, Lorenzo De Paoli, MD, Alfonso Maria D'Arco, MD, Andrea Gallamini, MD, Gianluca Gaidano, MD, PhD, Enrica Morra, MD, Massimo Massaia, MD, Marco Montillo, MD

Blood (2012) 120 (21): 2898.

https://doi.org/10.1182/blood.V120.21.2898.2898

Published: 2012

Journal Articles

Prevalence and Clinical Significance of the MYD88 (L265P) Somatic Mutation in Patients with Waldenström Macroglobulinemia, IgM-Monoclonal Gammopathy of Undetermined Significance or Other Mature B-Cell Neoplasms.

Marzia Varettoni, Luca Arcaini, Silvia Zibellini, Emanuela Boveri, Sara Rattotti, Roberta Riboni, Alessandro Corso, Ester Orlandi, Maurizio Bonfichi, Manuel Gotti, Cristiana Pascutto, Silvia Mangiacavalli, Lucia Morello, Maria Luisa Guerrera, Giorgio Croci, Valeria Fiaccadori, Marco Paulli, Mario Cazzola

Blood (2012) 120 (21): 2667.

https://doi.org/10.1182/blood.V120.21.2667.2667

Published: 2012

Journal Articles

Clues to the Pathogenesis of Waldenström Macroglobulinemia and Other Monoclonal IgM Disorders Provided by the Analysis of Immunoglobulin Heavy Chain Gene Rearrangement and Clustering of B-Cell Receptors,

Silvia Zibellini, Marzia Varettoni, Daniela Capello, Luca Arcaini, Davide Rossi, Ester Orlandi, Emanuela Boveri, Sara Rattotti, Cristiana Pascutto, Silvia Rizzi, Gianluca Gaidano, Mario Cazzola

Blood (2011) 118 (21): 3680.

https://doi.org/10.1182/blood.V118.21.3680.3680

Published: 2011

Journal Articles

Cytogenetic Aberration Profile of Chronic Myeloid Leukemia and Its Dynamic Changes During Imatinib Therapy,

Jelena D. Milosevic, Filip Razga, Dana Dvorakova, Tomas Jurcek, Tiina Berg, Ana Puda, Thorsten Klampfl, Ashot Harutyunyan, Bettina Gisslinger, Heinz Gisslinger, MD, Ester Orlandi, Paolo Bernasconi, Karel Indrak, Martina Divoka, Edgar Faber, Jiri Mayer, MD, Zdenek Racil, Robert Kralovics, PhD

Blood (2011) 118 (21): 3755.

https://doi.org/10.1182/blood.V118.21.3755.3755

Published: 2011

Journal Articles

CpG Oligonucleotide Combined with Interleukin-2 Reveals Unexpected Chromosomal Lesions In B-CLL

Paolo Bernasconi, MD, Marina Boni, PhD, Irene Dambruoso, PhD, Ilaria Giardini, PhD, Paola Maria Cavigliano, PhD, Barbara Rocca, BSc, Rita Zappatore, PhD, Celeste Calvello, PhD, Marilena Caresana, PhD, Lara Pochintesta, MD, Silvia Zibellini, Mario Lazzarino, Prof, Ester Orlandi, MD

Blood (2010) 116 (21): 2411.

https://doi.org/10.1182/blood.V116.21.2411.2411

Published: 2010

Journal Articles

Unmutated IGHV1-69/D3-16/J3 Stereotyped HCDR3 Rearrangements (Subset 6) Are Associated with Indolent Disease Course and Have Outcome Independent of Mutational Status In Early Stage CLL (Rai 0)

Blood (2010) 116 (21): 1371.

https://doi.org/10.1182/blood.V116.21.1371.1371

Published: 2010

Journal Articles

Dose Changing and Discontinuation of Imatinib In Patients Affected by Philadelphia Positive Chronic Myeloid Leukemia: a Longitudinal Analysis, a Single Centre Experience.

Serena Merante, MD, Cristiana Pascutto, PhD, Ester Orlandi, MD, Lara Pochintesta, MD, Marina Boni, BSc, Celeste Calvello, BSc, Barbara Rocca, BSc, Paolo Bernasconi, MD, Mario Lazzarino, Prof

Blood (2010) 116 (21): 4478.

https://doi.org/10.1182/blood.V116.21.4478.4478

Published: 2010

Journal Articles

Immunoglobulin Heavy Chain (IGH) Gene Rearrangement In Waldenström Macroglobulinemia and Other Monoclonal IgM Disorders

Marzia Varettoni, Silvia Zibellini, Luca Arcaini, Ester Orlandi, Cristiana Pascutto, Emanuela Boveri, Alessandro Corso, Francesco Passamonti, Silvia Mangiacavalli, MD, Silvia Rizzi, Lara Pochintesta, Marco Paulli, Enrica Morra, Mario Lazzarino

Blood (2010) 116 (21): 4139.

https://doi.org/10.1182/blood.V116.21.4139.4139

Published: 2010

Journal Articles

Fotemustine IN COMBINATION with BORTEZOMIB and DEXAMETHASONE: Encouraging PRELIMINARY RESULTS FROM A PHASE II STUDY On Relapsed REFRACTORY MYELOMA PATIENTS

Alessandro Corso, MD, Silvia Mangiacavalli, MD, Federica Cocito, MD, Cristiana Pascutto, Cesare Astori, MD, Marzia Varettoni, MD, Ester Orlandi, MD, Patrizia Zappasodi, MD, Silvia Rizzi, MD, Ilaria Ambaglio, MD, Mario Lazzarino, Prof, Mario Cazzola, MD

Blood (2010) 116 (21): 3037.

https://doi.org/10.1182/blood.V116.21.3037.3037

Published: 2010

Journal Articles

Stereotyped Patterns of HCDR3 Sequences in Splenic Marginal Zone B-Cell Lymphoma (SMZL): SMZL-Biased Subsets Are Associated with a Worse Outcome.

Blood (2009) 114 (22): 760.

https://doi.org/10.1182/blood.V114.22.760.760

Published: 2009

Journal Articles

Risk of Second Cancers in Waldenstrom Macroglobulinemia: a Population-Based Study From Northern Italy.

Marzia Varettoni, Alessandra Tedeschi, Cristiana Pascutto, Eleonora Vismara, Luca Arcaini, Antonino Greco, Ester Orlandi, Francesca Ricci, Alessandro Corso, Sara Miqueleiz, Cesare Astori, Mario Lazzarino, Enrica Morra

Blood (2009) 114 (22): 3951.

https://doi.org/10.1182/blood.V114.22.3951.3951

Published: 2009

Journal Articles

Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors

Blood (2009) 114 (10): 2168–2171.

https://doi.org/10.1182/blood-2009-01-197186

Published: 2009

Includes: Supplemental data

NARROW

A Novel Approach to a Retrospective Longitudinal Analysis of Dose Change or Discontinuation of Imatinib Therapy in Chronic Phase–Chronic Myeloid Leukemia

Gene Expression Profiling of CD34+/Lin- Cells of Patients with Chronic Myeloid Leukemia at Diagnosis and after 12 Months of Nilotinib

Microarray of Bone Marrow CD34+/Lin- Cells from Patients with Chronic Myeloid Leukemia (CML)

Gimema Registry of Conception/Pregnancy in Adult Patients Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKIs)

The e13a2 BCR-ABL1 Fusion Transcript Is a Candidate Adverse Prognostic Factor In Chronic Myeloid Leukemia Patients Treated Frontline With Imatinib Mesylate

A Phase II Multi-Center Trial Of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) In Older Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients

Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms

Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia.

Prevalence and Clinical Significance of the MYD88 (L265P) Somatic Mutation in Patients with Waldenström Macroglobulinemia, IgM-Monoclonal Gammopathy of Undetermined Significance or Other Mature B-Cell Neoplasms.

Clues to the Pathogenesis of Waldenström Macroglobulinemia and Other Monoclonal IgM Disorders Provided by the Analysis of Immunoglobulin Heavy Chain Gene Rearrangement and Clustering of B-Cell Receptors,

Cytogenetic Aberration Profile of Chronic Myeloid Leukemia and Its Dynamic Changes During Imatinib Therapy,

CpG Oligonucleotide Combined with Interleukin-2 Reveals Unexpected Chromosomal Lesions In B-CLL

Unmutated IGHV1-69/D3-16/J3 Stereotyped HCDR3 Rearrangements (Subset 6) Are Associated with Indolent Disease Course and Have Outcome Independent of Mutational Status In Early Stage CLL (Rai 0)

Dose Changing and Discontinuation of Imatinib In Patients Affected by Philadelphia Positive Chronic Myeloid Leukemia: a Longitudinal Analysis, a Single Centre Experience.

Immunoglobulin Heavy Chain (IGH) Gene Rearrangement In Waldenström Macroglobulinemia and Other Monoclonal IgM Disorders

Fotemustine IN COMBINATION with BORTEZOMIB and DEXAMETHASONE: Encouraging PRELIMINARY RESULTS FROM A PHASE II STUDY On Relapsed REFRACTORY MYELOMA PATIENTS

Stereotyped Patterns of HCDR3 Sequences in Splenic Marginal Zone B-Cell Lymphoma (SMZL): SMZL-Biased Subsets Are Associated with a Worse Outcome.

Risk of Second Cancers in Waldenstrom Macroglobulinemia: a Population-Based Study From Northern Italy.

Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only